Inhibition of CDK1 activity can successfully suppress the in vitro and in vivo tumor growth of PAAD, further proving the pivotal role of CDK1 pathway in PAAD progression [38]. The gene discussed is CDK1; the disease is pancreatic adenocarcinoma.